Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies.
Highlighted with 78 tables and 119 figures, this 215-page report “Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
o Granulocyte Colony Stimulating Factor
o P53 Protein
o P38 Protein
o Other Purified Proteins
o Amyloid Protein
o Defensin
o Transferrin
o Recombinant Insulin
o Other Recombinant Hormones
? Cancer Vaccines
? Malaria Vaccines
? Ebola Vaccines
? Hepatitis Vaccines
? Tetanus Vaccines
? Diphtheria Vaccines
? Cholera Vaccines
? Other Recombinant Vaccines
o Conventional Vaccines
? Polio Vaccines
? Pox Vaccines
? Other Conventional Vaccines
o Cyclase
o Caspase
o Cathepsin
o Autologous Products
o Acellular Products
o Other Products
Based on Testing Service, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
Highlighted with 78 tables and 119 figures, this 215-page report “Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Monoclonal Antibodies
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
- Recombinant Growth Factors
o Granulocyte Colony Stimulating Factor
- Purified Proteins
o P53 Protein
o P38 Protein
o Other Purified Proteins
- Recombinant Proteins
o Amyloid Protein
o Defensin
o Transferrin
- Recombinant Hormones
o Recombinant Insulin
o Other Recombinant Hormones
- Vaccines
? Cancer Vaccines
? Malaria Vaccines
? Ebola Vaccines
? Hepatitis Vaccines
? Tetanus Vaccines
? Diphtheria Vaccines
? Cholera Vaccines
? Other Recombinant Vaccines
o Conventional Vaccines
? Polio Vaccines
? Pox Vaccines
? Other Conventional Vaccines
- Recombinant Enzymes
o Cyclase
o Caspase
o Cathepsin
- Cell and Gene Therapies
o Autologous Products
o Acellular Products
- Synthetic Immunomodulators
- Other Product Types
o Other Products
Based on Testing Service, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Laboratory Testing
- Custom Testing/Customer Proprietary Testing
- Compendial and Multi Compendial Laboratory Testing
- Formulation Excipients
- Active Pharmaceutical Ingredients (API)
- Other Materials
- Innovative Biopharmaceuticals
- Biogenerics and Biosimilars
- Oncology
- Inflammatory and Infectious Diseases
- Autoimmune Disorders
- Metabolic Disorders
- Hormonal Disorders
- Cardiovascular Diseases
- Neurological Diseases
- Other Therapeutic Areas
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Monoclonal Antibodies
3.2.1 Anti-cancer Monoclonal Antibodies
3.2.2 Anti-inflammatory Monoclonal Antibodies
3.2.3 Other Monoclonal Antibodies
3.3 Recombinant Growth Factors
3.3.1 Erythropoietin
3.3.2 Granulocyte Colony Stimulating Factor
3.4 Purified Proteins
3.4.1 Leukemia Inhibitory Factor (LIF)
3.4.2 P53 Protein
3.4.3 P38 Protein
3.4.4 Other Purified Proteins
3.5 Recombinant Proteins
3.5.1 Serum Albumin
3.5.2 Amyloid Protein
3.5.3 Defensin
3.5.4 Transferrin
3.6 Recombinant Hormones
3.6.1 Recombinant Human Growth Hormones
3.6.2 Recombinant Insulin
3.6.3 Other Recombinant Hormones
3.7 Vaccines
3.7.1 Recombinant Vaccines
3.7.2 Conventional Vaccines
3.8 Recombinant Enzymes
3.8.1 Enterokinase
3.8.2 Cyclase
3.8.3 Caspase
3.8.4 Cathepsin
3.9 Cell and Gene Therapies
3.9.1 Allogenic Products
3.9.2 Autologous Products
3.9.3 Acellular Products
3.10 Synthetic Immunomodulators
3.11 Other Product Types
3.11.1 Blood Factors
3.11.2 Other Products
4 SEGMENTATION OF GLOBAL MARKET BY TESTING SERVICE
4.1 Market Overview by Testing Service
4.2 Laboratory Testing
4.3 Custom Testing/Customer Proprietary Testing
4.4 Compendial and Multi Compendial Laboratory Testing
5 SEGMENTATION OF GLOBAL MARKET BY RAW MATERIAL
5.1 Market Overview by Raw Material
5.2 Formulation Excipients
5.3 Active Pharmaceutical Ingredients (API)
5.4 Other Materials
6 SEGMENTATION OF GLOBAL MARKET BY CLASSIFICATION
6.1 Market Overview by Classification
6.2 Innovative Biopharmaceuticals
6.3 Biogenerics and Biosimilars
7 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC AREA
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Inflammatory and Infectious Diseases
7.4 Autoimmune Disorders
7.5 Metabolic Disorders
7.6 Hormonal Disorders
7.7 Cardiovascular Diseases
7.8 Neurological Diseases
7.9 Other Therapeutic Areas
8 SEGMENTATION OF GLOBAL MARKET BY REGION
8.1 Geographic Market Overview 2023-2033
8.2 North America Market 2023-2033 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2023-2033 by Country
8.3.1 Overview of European Market
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Spain
8.3.6 Italy
8.3.7 Netherlands
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2023-2033 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2023-2033 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2023-2033 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Monoclonal Antibodies
3.2.1 Anti-cancer Monoclonal Antibodies
3.2.2 Anti-inflammatory Monoclonal Antibodies
3.2.3 Other Monoclonal Antibodies
3.3 Recombinant Growth Factors
3.3.1 Erythropoietin
3.3.2 Granulocyte Colony Stimulating Factor
3.4 Purified Proteins
3.4.1 Leukemia Inhibitory Factor (LIF)
3.4.2 P53 Protein
3.4.3 P38 Protein
3.4.4 Other Purified Proteins
3.5 Recombinant Proteins
3.5.1 Serum Albumin
3.5.2 Amyloid Protein
3.5.3 Defensin
3.5.4 Transferrin
3.6 Recombinant Hormones
3.6.1 Recombinant Human Growth Hormones
3.6.2 Recombinant Insulin
3.6.3 Other Recombinant Hormones
3.7 Vaccines
3.7.1 Recombinant Vaccines
3.7.2 Conventional Vaccines
3.8 Recombinant Enzymes
3.8.1 Enterokinase
3.8.2 Cyclase
3.8.3 Caspase
3.8.4 Cathepsin
3.9 Cell and Gene Therapies
3.9.1 Allogenic Products
3.9.2 Autologous Products
3.9.3 Acellular Products
3.10 Synthetic Immunomodulators
3.11 Other Product Types
3.11.1 Blood Factors
3.11.2 Other Products
4 SEGMENTATION OF GLOBAL MARKET BY TESTING SERVICE
4.1 Market Overview by Testing Service
4.2 Laboratory Testing
4.3 Custom Testing/Customer Proprietary Testing
4.4 Compendial and Multi Compendial Laboratory Testing
5 SEGMENTATION OF GLOBAL MARKET BY RAW MATERIAL
5.1 Market Overview by Raw Material
5.2 Formulation Excipients
5.3 Active Pharmaceutical Ingredients (API)
5.4 Other Materials
6 SEGMENTATION OF GLOBAL MARKET BY CLASSIFICATION
6.1 Market Overview by Classification
6.2 Innovative Biopharmaceuticals
6.3 Biogenerics and Biosimilars
7 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC AREA
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Inflammatory and Infectious Diseases
7.4 Autoimmune Disorders
7.5 Metabolic Disorders
7.6 Hormonal Disorders
7.7 Cardiovascular Diseases
7.8 Neurological Diseases
7.9 Other Therapeutic Areas
8 SEGMENTATION OF GLOBAL MARKET BY REGION
8.1 Geographic Market Overview 2023-2033
8.2 North America Market 2023-2033 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2023-2033 by Country
8.3.1 Overview of European Market
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Spain
8.3.6 Italy
8.3.7 Netherlands
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2023-2033 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2023-2033 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2023-2033 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Global Biopharmaceuticals Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 8. Worldwide Number of New Cancer by Type, 2020
Table 9. Main Product Trends and Market Opportunities in Global Biopharmaceuticals Market
Table 10. Global Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 11. Global Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn
Table 12. Global Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn
Table 13. Global Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn
Table 14. Global Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn
Table 15. Global Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022
Table 17. Global Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn
Table 18. Global Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn
Table 19. Global Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn
Table 20. Global Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn
Table 21. Global Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn
Table 22. Global Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn
Table 23. Global Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn
Table 24. Global Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn
Table 25. Global Biopharmaceuticals Market by Classification, 2023-2033, $ mn
Table 26. Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 27. Global Biopharmaceuticals Market by Region, 2023-2033, $ mn
Table 28. Leading National Biopharmaceuticals Market, 2023 and 2033, $ mn
Table 29. North America Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 30. U.S. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 31. U.S. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 32. Canada Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 33. Canada Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 34. Mexico Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 35. Mexico Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 36. Europe Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 37. Germany Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 38. Germany Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 39. U.K. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 40. U.K. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 41. France Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 42. France Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 43. Spain Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 44. Spain Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 45. Italy Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 46. Italy Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 47. Netherlands Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 48. Netherlands Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 49. Biopharmaceuticals Market in Rest of Europe by Country, 2023-2033, $ mn
Table 50. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 51. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 52. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 53. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 54. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 55. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 56. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 57. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 58. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 59. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 60. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 61. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 62. South America Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 63. Argentina Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 64. Argentina Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 65. Brazil Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 66. Brazil Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 67. Chile Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 68. Chile Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 69. MEA Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 70. UAE Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 71. UAE Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 72. Saudi Arabia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 73. Saudi Arabia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 74. South Africa Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 75. South Africa Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 76. Abbott Laboratories: Company Snapshot
Table 77. Abbott Laboratories: Business Segmentation
Table 78. Abbott Laboratories: Product Portfolio
Table 1. Snapshot of Global Biopharmaceuticals Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 8. Worldwide Number of New Cancer by Type, 2020
Table 9. Main Product Trends and Market Opportunities in Global Biopharmaceuticals Market
Table 10. Global Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 11. Global Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn
Table 12. Global Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn
Table 13. Global Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn
Table 14. Global Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn
Table 15. Global Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022
Table 17. Global Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn
Table 18. Global Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn
Table 19. Global Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn
Table 20. Global Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn
Table 21. Global Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn
Table 22. Global Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn
Table 23. Global Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn
Table 24. Global Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn
Table 25. Global Biopharmaceuticals Market by Classification, 2023-2033, $ mn
Table 26. Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 27. Global Biopharmaceuticals Market by Region, 2023-2033, $ mn
Table 28. Leading National Biopharmaceuticals Market, 2023 and 2033, $ mn
Table 29. North America Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 30. U.S. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 31. U.S. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 32. Canada Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 33. Canada Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 34. Mexico Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 35. Mexico Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 36. Europe Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 37. Germany Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 38. Germany Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 39. U.K. Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 40. U.K. Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 41. France Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 42. France Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 43. Spain Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 44. Spain Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 45. Italy Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 46. Italy Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 47. Netherlands Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 48. Netherlands Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 49. Biopharmaceuticals Market in Rest of Europe by Country, 2023-2033, $ mn
Table 50. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 51. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 52. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 53. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 54. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 55. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 56. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 57. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 58. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 59. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 60. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 61. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 62. South America Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 63. Argentina Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 64. Argentina Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 65. Brazil Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 66. Brazil Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 67. Chile Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 68. Chile Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 69. MEA Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 70. UAE Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 71. UAE Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 72. Saudi Arabia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 73. Saudi Arabia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 74. South Africa Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 75. South Africa Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 76. Abbott Laboratories: Company Snapshot
Table 77. Abbott Laboratories: Business Segmentation
Table 78. Abbott Laboratories: Product Portfolio
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Global Biopharmaceuticals Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Biopharmaceuticals Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022
Figure 10. Primary Restraints and Impact Factors of Global Biopharmaceuticals Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Biopharmaceuticals Market
Figure 13. Breakdown of Global Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue
Figure 14. Global Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%)
Figure 15. Global Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn
Figure 16. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn
Figure 17. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn
Figure 18. Global Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn
Figure 19. Global Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn
Figure 20. Global Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn
Figure 21. Global Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn
Figure 22. Global Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn
Figure 23. Global Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn
Figure 24. Global Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn
Figure 25. Global Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn
Figure 26. Global Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn
Figure 27. Global Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn
Figure 28. Global Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn
Figure 29. Global Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn
Figure 30. Global Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn
Figure 31. Global Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn
Figure 32. Global Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn
Figure 33. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn
Figure 34. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn
Figure 35. Global Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn
Figure 36. Global Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn
Figure 37. Global Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn
Figure 38. Global Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn
Figure 39. Global Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn
Figure 40. Global Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn
Figure 41. Global Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn
Figure 42. Global Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn
Figure 43. Global Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn
Figure 44. Global Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn
Figure 45. Global Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn
Figure 46. Global Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn
Figure 47. Global Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn
Figure 48. Global Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn
Figure 49. Global Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn
Figure 50. Global Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn
Figure 51. Global Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn
Figure 52. Breakdown of Global Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue
Figure 53. Global Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%)
Figure 54. Global Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn
Figure 55. Global Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn
Figure 56. Global Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn
Figure 57. Breakdown of Global Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue
Figure 58. Global Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%)
Figure 59. Global Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn
Figure 60. Global Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn
Figure 61. Global Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn
Figure 62. Breakdown of Global Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue
Figure 63. Global Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%)
Figure 64. Global Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn
Figure 65. Global Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn
Figure 66. Breakdown of Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue
Figure 67. Global Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 68. Global Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn
Figure 69. Global Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn
Figure 70. Global Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn
Figure 71. Global Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn
Figure 72. Global Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn
Figure 73. Global Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn
Figure 74. Global Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn
Figure 75. Global Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn
Figure 76. Global Market Snapshot by Region
Figure 77. Geographic Spread of Worldwide Biopharmaceuticals Market, 2023-2033, % of Sales Revenue
Figure 78. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 79. North American Biopharmaceuticals Market, 2023-2033, $ mn
Figure 80. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 81. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. U.S. Biopharmaceuticals Market, 2023-2033, $ mn
Figure 83. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts
Figure 84. Canada Biopharmaceuticals Market, 2023-2033, $ mn
Figure 85. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn
Figure 86. European Biopharmaceuticals Market, 2023-2033, $ mn
Figure 87. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 88. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 89. Biopharmaceuticals Market in Germany, 2023-2033, $ mn
Figure 90. Biopharmaceuticals Market in U.K., 2023-2033, $ mn
Figure 91. Biopharmaceuticals Market in France, 2023-2033, $ mn
Figure 92. Biopharmaceuticals Market in Spain, 2023-2033, $ mn
Figure 93. Biopharmaceuticals Market in Italy, 2023-2033, $ mn
Figure 94. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn
Figure 95. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn
Figure 96. Asia-Pacific Biopharmaceuticals Market, 2023-2033, $ mn
Figure 97. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 98. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 99. Biopharmaceuticals Market in Japan, 2023-2033, $ mn
Figure 100. Biopharmaceuticals Market in China, 2023-2033, $ mn
Figure 101. Biopharmaceuticals Market in Australia, 2023-2033, $ mn
Figure 102. Biopharmaceuticals Market in India, 2023-2033, $ mn
Figure 103. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn
Figure 104. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn
Figure 105. South America Biopharmaceuticals Market, 2023-2033, $ mn
Figure 106. Breakdown of South America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 107. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 108. Biopharmaceuticals Market in Argentina, 2023-2033, $ mn
Figure 109. Biopharmaceuticals Market in Brazil, 2023-2033, $ mn
Figure 110. Biopharmaceuticals Market in Chile, 2023-2033, $ mn
Figure 111. Biopharmaceuticals Market in Rest of South America, 2023-2033, $ mn
Figure 112. Biopharmaceuticals Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 113. Breakdown of MEA Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 114. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 115. Biopharmaceuticals Market in UAE, 2023-2033, $ mn
Figure 116. Biopharmaceuticals Market in Saudi Arabia, 2023-2033, $ mn
Figure 117. Biopharmaceuticals Market in South Africa, 2023-2033, $ mn
Figure 118. Growth Stage of Global Biopharmaceuticals Industry over the Forecast Period
Figure 119. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Global Biopharmaceuticals Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Biopharmaceuticals Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022
Figure 10. Primary Restraints and Impact Factors of Global Biopharmaceuticals Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Biopharmaceuticals Market
Figure 13. Breakdown of Global Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue
Figure 14. Global Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%)
Figure 15. Global Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn
Figure 16. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn
Figure 17. Global Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn
Figure 18. Global Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn
Figure 19. Global Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn
Figure 20. Global Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn
Figure 21. Global Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn
Figure 22. Global Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn
Figure 23. Global Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn
Figure 24. Global Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn
Figure 25. Global Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn
Figure 26. Global Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn
Figure 27. Global Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn
Figure 28. Global Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn
Figure 29. Global Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn
Figure 30. Global Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn
Figure 31. Global Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn
Figure 32. Global Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn
Figure 33. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn
Figure 34. Global Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn
Figure 35. Global Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn
Figure 36. Global Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn
Figure 37. Global Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn
Figure 38. Global Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn
Figure 39. Global Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn
Figure 40. Global Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn
Figure 41. Global Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn
Figure 42. Global Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn
Figure 43. Global Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn
Figure 44. Global Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn
Figure 45. Global Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn
Figure 46. Global Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn
Figure 47. Global Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn
Figure 48. Global Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn
Figure 49. Global Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn
Figure 50. Global Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn
Figure 51. Global Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn
Figure 52. Breakdown of Global Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue
Figure 53. Global Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%)
Figure 54. Global Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn
Figure 55. Global Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn
Figure 56. Global Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn
Figure 57. Breakdown of Global Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue
Figure 58. Global Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%)
Figure 59. Global Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn
Figure 60. Global Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn
Figure 61. Global Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn
Figure 62. Breakdown of Global Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue
Figure 63. Global Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%)
Figure 64. Global Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn
Figure 65. Global Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn
Figure 66. Breakdown of Global Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue
Figure 67. Global Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 68. Global Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn
Figure 69. Global Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn
Figure 70. Global Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn
Figure 71. Global Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn
Figure 72. Global Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn
Figure 73. Global Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn
Figure 74. Global Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn
Figure 75. Global Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn
Figure 76. Global Market Snapshot by Region
Figure 77. Geographic Spread of Worldwide Biopharmaceuticals Market, 2023-2033, % of Sales Revenue
Figure 78. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 79. North American Biopharmaceuticals Market, 2023-2033, $ mn
Figure 80. Breakdown of North America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 81. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. U.S. Biopharmaceuticals Market, 2023-2033, $ mn
Figure 83. Venture Capital Deal Activity and Investment Flows in the U.S., 2013-2022, $ bn and Deal Counts
Figure 84. Canada Biopharmaceuticals Market, 2023-2033, $ mn
Figure 85. Biopharmaceuticals Market in Mexico, 2023-2033, $ mn
Figure 86. European Biopharmaceuticals Market, 2023-2033, $ mn
Figure 87. Breakdown of European Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 88. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 89. Biopharmaceuticals Market in Germany, 2023-2033, $ mn
Figure 90. Biopharmaceuticals Market in U.K., 2023-2033, $ mn
Figure 91. Biopharmaceuticals Market in France, 2023-2033, $ mn
Figure 92. Biopharmaceuticals Market in Spain, 2023-2033, $ mn
Figure 93. Biopharmaceuticals Market in Italy, 2023-2033, $ mn
Figure 94. Biopharmaceuticals Market in Netherlands, 2023-2033, $ mn
Figure 95. Biopharmaceuticals Market in Rest of Europe, 2023-2033, $ mn
Figure 96. Asia-Pacific Biopharmaceuticals Market, 2023-2033, $ mn
Figure 97. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 98. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 99. Biopharmaceuticals Market in Japan, 2023-2033, $ mn
Figure 100. Biopharmaceuticals Market in China, 2023-2033, $ mn
Figure 101. Biopharmaceuticals Market in Australia, 2023-2033, $ mn
Figure 102. Biopharmaceuticals Market in India, 2023-2033, $ mn
Figure 103. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn
Figure 104. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn
Figure 105. South America Biopharmaceuticals Market, 2023-2033, $ mn
Figure 106. Breakdown of South America Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 107. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 108. Biopharmaceuticals Market in Argentina, 2023-2033, $ mn
Figure 109. Biopharmaceuticals Market in Brazil, 2023-2033, $ mn
Figure 110. Biopharmaceuticals Market in Chile, 2023-2033, $ mn
Figure 111. Biopharmaceuticals Market in Rest of South America, 2023-2033, $ mn
Figure 112. Biopharmaceuticals Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 113. Breakdown of MEA Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 114. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 115. Biopharmaceuticals Market in UAE, 2023-2033, $ mn
Figure 116. Biopharmaceuticals Market in Saudi Arabia, 2023-2033, $ mn
Figure 117. Biopharmaceuticals Market in South Africa, 2023-2033, $ mn
Figure 118. Growth Stage of Global Biopharmaceuticals Industry over the Forecast Period
Figure 119. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn
